Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Hilversum
Clinical trial register · Netherlands

Clinical Trials in Hilversum, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Netherlands and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3171 matching records held by the registry are in this view. Synced 10 Nov 2026, 03:17 UTC
3171
Studies in scope
all four open statuses
1789
Recruiting now
open to new participants
601
Lead sponsors
across recruiting studies
Top sites
Amsterdam 1239 Rotterdam 853 Groningen 601 Nijmegen 565 Utrecht 543
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca6 Amsterdam UMC, location VUmc3 Pfizer3 Radboud University Medical Center2 Merck Sharp & Dohme LLC2 Janssen Research & Development, LLC2 Bayer2 Eli Lilly and Company2 Tergooi Medical Center2 University of Amsterdam1 Dutch Society of Physicians for Pulmonology and Tuberculosis1 Zai Lab (Shanghai) Co., Ltd.1 Marjolein Spiering1 The Netherlands Cancer Institute1 JointResearch1 Jeroen van Eijk1 Amgen1 BeOne Medicines1 UNICANCER1 Memorial Sloan Kettering Cancer Center1 Alzheimercentrum Amsterdam1 M.A. Med Alliance S.A.1 Nick van der Beek1 Jord Vink1 Catharina Ziekenhuis Eindhoven1 Show all 27
Site location
Amsterdam1239 Rotterdam853 Groningen601 Nijmegen565 Utrecht543 Maastricht420 Leiden385 Eindhoven208 Arnhem182 Breda172 Nieuwegein149 The Hague121 's-Hertogenbosch119 Tilburg114 Zwolle109 Enschede107 Dordrecht103 Amersfoort96 Leeuwarden87 Alkmaar86 Heerlen65 Delft60 Deventer59 Apeldoorn52 Almelo51 Show all 164
All 164 locations
Target enrolment
to

Trials with a site in Hilversum

42 of 3171 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Netherlands
Start
Active, closed
Jeroen van Eijk
Not applicable
3,200
Alkmaar, Amsterdam, Hilversum
2026-10-05
Not yet open
Perceptions of De-implementing Routine Follow-ups After Hip and Knee Arthroplasty
NCT07041528Hip Arthroplasty, Total, Knee Arthroplasty, Total
Tergooi Medical Center
Observational
90
Hilversum
2026-09-01
Recruiting
Amgen
Phase 3
406
Hilversum
2026-03-23
Recruiting
UNICANCER
Phase 3
3,902
Arnhem, Hilversum, Hoofddorp, Leeuwarden, Leiden, Venlo
2025-12-18
Recruiting
Zai Lab (Shanghai) Co., Ltd.
Phase 3
480
Breda, Hilversum
2025-11-30
Recruiting
Pfizer
Phase 3
1,000
Nijmegen, Hilversum, Delft
2025-09-28
Recruiting
Alzheimercentrum Amsterdam
Not applicable
550
Amsterdam, 's-Hertogenbosch, Almere Stad, Haarlem, Hilversum, Leeuwarden, Purmerend, Tilburg
2025-09-17
Recruiting
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
NCT07157774Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD)
Eli Lilly and Company
Phase 3
10,450
Alkmaar, Almere Stad, Amersfoort, Amsterdam, Arnhem, Born, Ede, Hilversum
2025-09-02
Recruiting
Janssen Research & Development, LLC
Phase 3
1,203
Delft, Groningen, Hilversum, Hoofddorp, Maastricht, Nijmegen, Rotterdam, Zwolle
2025-09-02
Not yet open
Nick van der Beek
Not applicable
47
Hilversum
2025-09-01
Recruiting
Prospective Data Collection Initiative on Thoracic Malignancies
NCT06996249Lung Cancer, Thoracic Cancer, Lung Cancer, Nonsmall Cell, Adenocarcinoma
Dutch Society of Physicians for Pulmonology and Tuberculosis
Observational
12,000
Ede, Eindhoven, Hilversum, Utrecht, Alkmaar, Amersfoort, Amsterdam, Breda
2025-08-15
Recruiting
AstraZeneca
Phase 3
700
Hilversum, Hoofddorp, Maastricht, Nijmegen, Roosendaal
2025-08-06
Recruiting
Pfizer
Phase 3
400
Hilversum, Schiedam
2025-08-05
Recruiting
JointResearch
Not applicable
1,000
Amsterdam, Breda, Deventer, Goes, Groningen, Hilversum, Nijmegen, Terneuzen
2025-07-01
Recruiting
Hold me Tight/Let me Go: Effectiveness of a Course to Enhance Parent-adolescent Relationship
NCT06966323Parent Training, Parent Child Relationship, Parent-child Problem
University of Amsterdam
Observational
150
Almere Stad, Bilthoven, Hilversum, Woerden
2025-06-11
Recruiting
BeOne Medicines
Phase 3
630
Almere Stad, Arnhem, Dordrecht, Hilversum
2025-06-11
Recruiting
Tergooi Medical Center
Not applicable
56
Hilversum
2025-05-21
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,440
Nijmegen, Maastricht, Venlo, Amsterdam, Hilversum, Hoofddorp, Hengelo, Rotterdam
2025-05-13
Recruiting
AstraZeneca
Phase 3
5,000
Amersfoort, Amsterdam, Dordrecht, Groningen, Hilversum, Leiden, Maastricht, Nieuwegein
2025-03-03
Recruiting
Jord Vink
Not applicable
454
's-Hertogenbosch, Amsterdam, Beetsterzwaag, Breda, Doorn, Eindhoven, Groesbeek, Hilversum
2024-12-09
Active, closed
Pfizer
Phase 3
609
Nijmegen, Hilversum, Leeuwarden, Amersfoort
2024-10-21
Recruiting
Improved Prescribing for Older Nursing Home Patients
NCT06731361Nursing Home Residents, Older People, Prescribing, Advance Care Planning
Amsterdam UMC, location VUmc
Not applicable
450
Apeldoorn, Harderwijk, Amsterdam, Hilversum, IJsselstein, Vianen, Groningen
2024-09-10
Recruiting
Amsterdam UMC, location VUmc
Not applicable
66
Emmen, Almere Stad, Valkenburg, Breda, Amsterdam, Heemskerk, Hilversum, Enschede
2024-07-19
Active, closed
Brief-intensive CBT Versus Once-weekly CBT in Anxiety-related Disorders
NCT05942391Anxiety Disorders, Obsessive-Compulsive Disorder, Posttraumatic Stress Disorder, Hypochondriasis
Amsterdam UMC, location VUmc
Not applicable
120
Amstelveen, Amsterdam, Haarlem, Hilversum, Hoofddorp, Utrecht
2024-04-26
Active, closed
AstraZeneca
Phase 3
2,554
Alkmaar, Amersfoort, Dordrecht, Hardenberg, Harderwijk, Hilversum, Utrecht
2024-03-29
Recruiting
Radboud University Medical Center
Not applicable
690
Hilversum, Amsterdam, Apeldoorn & Zutphen, Breda, Deventer, Ede, Eindhoven & Veldhoven, Emmen
2024-03-19
Recruiting
Translumina Therapeutics Pvt Ltd.
Observational
2,000
Amsterdam, Hilversum, Venlo
2024-01-10
Recruiting
Eli Lilly and Company
Phase 3
1,264
's-Hertogenbosch, Enschede, Harderwijk, Hilversum, Leeuwarden, Leiden, Rotterdam, Tilburg
2023-12-21
Active, closed
AstraZeneca
Phase 3
1,898
Amsterdam, Hilversum, Nijmegen
2023-11-21
Active, closed
Marjolein Spiering
Observational
305
Haarlem, Hilversum
2023-04-23
Active, closed
Bayer
Phase 3
985
Hilversum, Dordrecht, Rotterdam, The Hague, Nieuwegein, Groningen
2023-04-03
Recruiting
What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI?
NCT04436978Acute Coronary Syndrome, Myocardial Infarction, Atrial Fibrillation, Atrial Flutter
St. Antonius Hospital
Phase 4
2,000
Alkmaar, Amsterdam, Eindhoven, Emmen, Heerlen, Hilversum, Nieuwegein, The Hague
2023-01-11
Recruiting
Predicting Response In Cervical Intraepithelial Neoplasia to Topical Imiquimod Treatment
NCT05405270Cervical High Grade Squamous Intraepithelial Lesion, Cervical Intraepithelial Neoplasia Grade 2/3, CIN 2/3, Cervical Intraepithelial Neoplasia
DrugImiquimod
Catharina Ziekenhuis Eindhoven
Observational
410
Breda, Dordrecht, Eindhoven, Hilversum, Leeuwarden, Leiden, Maastricht, Nijmegen
2022-06-01
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,800
Arnhem, Nijmegen, Maastricht, Breda, Eindhoven, Amsterdam, Hilversum, Hoofddorp
2022-03-15
Active, closed
The SELUTION DeNovo Study
NCT04859985Coronary Artery Disease
M.A. Med Alliance S.A.
Not applicable
3,326
Amsterdam, Groningen, Hilversum, Utrecht
2021-05-15
Active, closed
Bayer
Phase 3
774
Geleen, Tilburg, Amsterdam, Hilversum, Hoofddorp, Dordrecht, The Hague
2020-10-20
By invitation
The NetherLands Registry of Invasive Coronary Vasomotor Function Testing (NL-CFT)
NCT06083155Coronary Vasospasm, Coronary Microvascular Dysfunction, Non-Obstructive Coronary Atherosclerosis
Radboud University Medical Center
Observational
2,000
Nijmegen, Amsterdam, Arnhem, Breda, Eindhoven, Enschede, Hilversum, Leeuwarden
2020-10-15
Active, closed
Janssen Research & Development, LLC
Phase 3
696
Delft, Hilversum, Nijmegen, Tilburg
2020-09-23
Active, closed
AstraZeneca
Phase 3
1,012
Amsterdam, Hilversum, Roosendaal, The Hague, Tilburg, Utrecht
2020-07-13
Active, closed
AstraZeneca
Phase 3
895
Hilversum, Nijmegen, Tilburg
2018-10-31
Active, closed
Memorial Sloan Kettering Cancer Center
Phase 3
732
Amsterdam, Alkmaar, Almelo, Breda, Deventer, Hilversum, Nijmegen, Rotterdam
2018-06-19
Recruiting
The Netherlands Cancer Institute
Phase 2
353
Amsterdam, Eindhoven, Haarlem, Hilversum, The Hague
2017-03-29
Rows per page Showing 1–42 of 42
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Dutch investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 November 2026. https://priyalifescience.com/clinical-trials-netherlands/city/hilversum

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Netherlands and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,171 studies in total at the last sync on 10 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 42 of those studies with a site in Hilversum.

How many clinical trials are recruiting in Hilversum?

25 of the 42 studies on this page are recruiting new participants as of the 10 Nov 2026, 03:17 UTC sync. A further 2 have not yet opened recruitment, 14 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Hilversum), 42 studies
PhaseStudiesRecruitingShare
Phase 3221252.4%
Not applicable11726.2%
Observational7416.7%
Phase 2112.4%
Phase 4112.4%

Most active sponsors

Lead sponsors with the most studies (Hilversum)
Lead sponsorStudiesRecruiting
AstraZeneca62
Amsterdam UMC, location VUmc32
Pfizer32
Bayer20
Eli Lilly and Company22
Janssen Research & Development, LLC21
Merck Sharp & Dohme LLC21
Radboud University Medical Center21
Tergooi Medical Center21
Alzheimercentrum Amsterdam11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.